Stoke Therapeutics, Inc. — Director's Dealing 2019

Sep 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Stoke Therapeutics, Inc. (STOK)
CIK: 0001623526
Period of Report: 2019-09-10

Reporting Person: LEVIN ARTHUR A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-10	Director Stock Option (Right to Buy)	$28.80	A	14777	Acquired	2029-09-09	Common Stock (14777)	Direct

Footnotes

F1: This option vests 100% and becomes exercisable on June 21, 2020, subject to reporting person's continued service through such vesting date